Immuno-oncology treatment pre-surgery safe and effective option for localized non-small cell lung cancer
byOhio State University Medical CenterRelationship between MPR, histology, and TMB. (a) Pathologic response by mutation status (n = 85). TMB showed a positive but not significant trend with path
Updated on: December 26,2023
Immuno-oncology treatment pre-surgery safe and effective option for localized non-small cell lung cancer
byOhio State University Medical CenterRelationship between MPR, histology, and TMB. (a) Pathologic response by mutation status (n = 85). TMB showed a positive but not significant trend with path
Updated on:December 26,2023
